Metastasis Targeted Therapies in Renal Cell Cancer
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 1
Abstract
Metastatic renal cell cancer is a malignant disease and its treatment has been not been described clearly yet. These patients are generally symptomatic and resistant to current treatment modalities. Radiotherapy, chemotherapy, and hormonal therapy are not curative in many of these patients. A multimodal approach consisting of cytoreductive nephrectomy, systemic therapy (immunotherapy or targeted molecules), and metastasectomy has been shown to be hopeful in prolonging the survival and improving the quality of life in some of these patients. Patients with oligometastatic disease and good performance status have better results following this multimodal approach. Cytoreductive nephrectomy and adjuvant/neoadjuvant systemic therapies (immunotherapy, targeted therapy) have been investigated for treatment options of metastatic renal cancer patients. After better understanding of the genetic basis and the molecular biology of the renal cell carcinoma, targeted molecular therapies and immunotherapies have emerged as more efficient alternative therapy options with moderate adverse effects. Metastasectomy in some of these patients improves survival and quality of life, especially in those with lung and bone metastases. In this review we will summarize treatment options for metastatic renal cancer patients.
Authors and Affiliations
K. Fehmi Narter, Bora Özveren
Keywords
Related Articles
- EP ID EP379708
- DOI 10.4274/uob.962
- Views 135
- Downloads 0
Should We Perform Thoracic Imaging for Every Patient with a Renal Mass?
Objective: Current guidelines for the management of renal mass recommend thoracic imaging for potential metastatic nodules. Small size of the renal mass can be associated with low metastatic potential, which might questi...
Prostate and Bladder Metastases of Malignant Melanoma: Case Report
Prostate or bladder metastases of malignant melanoma (MM) are rarely encountered in clinical practice. To our knowledge, coexistence of prostate and bladder metastasis of MM has not been reported to date. We present the...
Immunotherapy in Prostate Cancer
In recent years, immunotherapy has become an important treatment alternative in the treatment of many cancers. Research on immunotherapy in prostate cancer has been accelerated by obtaining Food and Drug Administration (...
Evaluation of Role of Inflammatory Markers for the Prediction of Recurrence on Pathologic T1a Clear Cell Renal Cell Cancer Patients
Objective: To evaluate the role of neutrophil to lymphocyte ratio (NLR), high sensitive C-reactive protein (hs-CRP) and procalcitonin levels in the prediction of tumor recurrence in stage T1aN0M0 clear cell renal cell ca...
Evaluation of the Relationship Between Duration of Smoking and Clinical and Pathologic Characteristics of Bladder Cancer at Diagnosis
Objective In this study, we aimed to evaluate the relationship between the duration of smoking and clinical and pathological characteristics of malignant bladder cancer at diagnosis. Materials and Methods In this study,...